Annual Revenue
N/A
31 December 2023
Summary:
Madrigal Pharmaceuticals annual revenue is not available.MDGL Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Revenue
$62.17 M
+$47.54 M+324.75%
30 September 2024
Summary:
Madrigal Pharmaceuticals quarterly revenue is currently $62.17 million, with the most recent change of +$47.54 million (+324.75%) on 30 September 2024. MDGL quarterly revenue is now -52.32% below its all-time high of $130.41 million, reached on 30 September 2009.MDGL Quarterly Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Revenue
$76.81 M
+$62.17 M+424.75%
30 September 2024
Summary:
Madrigal Pharmaceuticals TTM revenue is currently $76.81 million, with the most recent change of +$62.17 million (+424.75%) on 30 September 2024. MDGL TTM revenue is now -46.75% below its all-time high of $144.25 million, reached on 31 December 2009.MDGL TTM Revenue Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MDGL Revenue Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | - | - |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
MDGL Revenue High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +324.8% | at high | +424.8% | ||
| 5 y | 5 years | at high | +324.8% | at high | +424.8% | ||
| alltime | all time | -52.3% | >+9999.0% | -46.8% | >+9999.0% |
Madrigal Pharmaceuticals Revenue History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $62.17 M(+324.8%) | $76.81 M(+424.8%) |
| June 2024 | - | $14.64 M(+9857.8%) | $14.64 M(+122.2%) |
| Dec 2012 | $147.00 K(-98.1%) | - | - |
| Mar 2012 | - | $147.00 K(-95.7%) | $6.59 M(-13.1%) |
| Dec 2011 | $7.58 M(-48.8%) | $3.42 M(+105.7%) | $7.58 M(-7.5%) |
| Sept 2011 | - | $1.66 M(+22.9%) | $8.20 M(-17.3%) |
| June 2011 | - | $1.35 M(+18.5%) | $9.92 M(-16.8%) |
| Mar 2011 | - | $1.14 M(-71.7%) | $11.92 M(-19.5%) |
| Dec 2010 | $14.80 M(-89.7%) | $4.04 M(+19.3%) | $14.80 M(-4.2%) |
| Sept 2010 | - | $3.38 M(+0.7%) | $15.45 M(-89.2%) |
| June 2010 | - | $3.36 M(-16.5%) | $142.47 M(-0.9%) |
| Mar 2010 | - | $4.02 M(-14.0%) | $143.76 M(-0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2009 | $144.25 M(+5416.1%) | $4.68 M(-96.4%) | $144.25 M(+2.9%) |
| Sept 2009 | - | $130.41 M(+2704.4%) | $140.20 M(+1166.7%) |
| June 2009 | - | $4.65 M(+3.1%) | $11.07 M(+42.7%) |
| Mar 2009 | - | $4.51 M(+609.1%) | $7.76 M(+69.2%) |
| Dec 2008 | $2.62 M(+252.0%) | $636.00 K(-50.0%) | $4.58 M(+16.1%) |
| Sept 2008 | - | $1.27 M(-4.9%) | $3.95 M(+47.5%) |
| June 2008 | - | $1.34 M(0.0%) | $2.68 M(+100.0%) |
| Mar 2008 | - | $1.34 M(+673.4%) | $1.34 M(+673.4%) |
| Dec 2007 | $743.00 K(+329.5%) | - | - |
| Dec 2004 | $173.00 K(-86.7%) | - | - |
| Mar 2004 | - | $173.00 K | $173.00 K |
| Dec 2003 | $1.30 M | - | - |
FAQ
- What is the all time high annual revenue for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals quarterly revenue?
- What is the all time high quarterly revenue for Madrigal Pharmaceuticals?
- What is Madrigal Pharmaceuticals TTM revenue?
- What is the all time high TTM revenue for Madrigal Pharmaceuticals?
What is the all time high annual revenue for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high annual revenue is $144.25 M
What is Madrigal Pharmaceuticals quarterly revenue?
The current quarterly revenue of MDGL is $62.17 M
What is the all time high quarterly revenue for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high quarterly revenue is $130.41 M
What is Madrigal Pharmaceuticals TTM revenue?
The current TTM revenue of MDGL is $76.81 M
What is the all time high TTM revenue for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals all-time high TTM revenue is $144.25 M